MERSANA THERAPEUTICS
2.2800
29-November-24 13:45:00
15 minutes delayed
Stocks
+0.0900
+4.11%
Today's range
2.1550 - 2.3100
ISIN
N/A
Source
NASDAQ
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 16:05:52 By Nasdaq GlobeNewswire
-
27 Jul 2023 07:06:23 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 Apr 2023 16:05:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 Mar 2023 19:10:38 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
02 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
01 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors
25 Jan 2023 08:00:01 By Nasdaq GlobeNewswire